DK163585C - Retinoidcarboxylsyre-mono- og -disaccharidestere, disse estere til anvendelse som laegemidler, isaer til behandling af neoplasi, acne eller psoriasis, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse estere samt anvendelse af esterne til fremstilling af et middel til behandling af neoplasi, acne eller psoriasis - Google Patents

Retinoidcarboxylsyre-mono- og -disaccharidestere, disse estere til anvendelse som laegemidler, isaer til behandling af neoplasi, acne eller psoriasis, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse estere samt anvendelse af esterne til fremstilling af et middel til behandling af neoplasi, acne eller psoriasis

Info

Publication number
DK163585C
DK163585C DK587384A DK587384A DK163585C DK 163585 C DK163585 C DK 163585C DK 587384 A DK587384 A DK 587384A DK 587384 A DK587384 A DK 587384A DK 163585 C DK163585 C DK 163585C
Authority
DK
Denmark
Prior art keywords
neoplasia
acne
psoriasis
esters
treatment
Prior art date
Application number
DK587384A
Other languages
English (en)
Other versions
DK587384A (da
DK587384D0 (da
DK163585B (da
Inventor
Werner Bollag
Hans Johann Mayer
Pierre-Charles Wyss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK587384D0 publication Critical patent/DK587384D0/da
Publication of DK587384A publication Critical patent/DK587384A/da
Publication of DK163585B publication Critical patent/DK163585B/da
Application granted granted Critical
Publication of DK163585C publication Critical patent/DK163585C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
DK587384A 1983-12-08 1984-12-07 Retinoidcarboxylsyre-mono- og -disaccharidestere, disse estere til anvendelse som laegemidler, isaer til behandling af neoplasi, acne eller psoriasis, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse estere samt anvendelse af esterne til fremstilling af et middel til behandling af neoplasi, acne eller psoriasis DK163585C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH657083 1983-12-08
CH6570/83A CH661516A5 (de) 1983-12-08 1983-12-08 Phenylnonatetraenoylzuckerderivate.

Publications (4)

Publication Number Publication Date
DK587384D0 DK587384D0 (da) 1984-12-07
DK587384A DK587384A (da) 1985-06-09
DK163585B DK163585B (da) 1992-03-16
DK163585C true DK163585C (da) 1992-08-24

Family

ID=4311671

Family Applications (1)

Application Number Title Priority Date Filing Date
DK587384A DK163585C (da) 1983-12-08 1984-12-07 Retinoidcarboxylsyre-mono- og -disaccharidestere, disse estere til anvendelse som laegemidler, isaer til behandling af neoplasi, acne eller psoriasis, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse estere samt anvendelse af esterne til fremstilling af et middel til behandling af neoplasi, acne eller psoriasis

Country Status (14)

Country Link
US (1) US4565863A (da)
JP (1) JPS60146896A (da)
AU (1) AU571278B2 (da)
BE (1) BE901210A (da)
CA (1) CA1234107A (da)
CH (1) CH661516A5 (da)
DE (1) DE3444051C2 (da)
DK (1) DK163585C (da)
FR (1) FR2556348B1 (da)
GB (1) GB2152498B (da)
IT (1) IT1177263B (da)
NL (1) NL8403554A (da)
SE (1) SE468987B (da)
ZA (1) ZA849364B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110801A (en) * 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
AT388166B (de) * 1986-06-03 1989-05-10 Oesterr Zuckerfab Evidenz Verfahren zur herstellung von neuen wasserloeslichen kohlenhydrat-derivaten
LU87035A1 (fr) * 1987-11-04 1989-06-14 Oreal Esters du type etretinique ou apparente d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
FR2644460A1 (fr) * 1989-03-16 1990-09-21 Oreal Esters retinoiques de d-desosamine, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2644459B1 (fr) * 1989-03-16 1994-10-28 Oreal Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
WO1990014092A1 (en) * 1989-05-18 1990-11-29 Cell Genesys, Inc. Single-strand site-directed modification of mammalian genes in vivo
EP0428668B1 (en) * 1989-05-22 1995-04-12 Iowa State University Research Foundation, Inc. Water-soluble vitamin a preparations for application to the skin
US5075340A (en) * 1989-05-22 1991-12-24 Iowa State University Research Foundation Retinoic acid glucuronide preparations for application to the skin
US5235076A (en) * 1991-05-28 1993-08-10 University Of Hawaii Azulenic retinoid compounds, compositions and methods
CH684092A5 (de) * 1992-04-21 1994-07-15 Ciba Geigy Ag Wasserlösliche Retinoide.
GB2282596B (en) * 1993-10-06 1998-04-15 Ciba Geigy Ag Water-soluble retinoids
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
FR2768630B1 (fr) * 1997-09-22 2000-08-04 Ulice Sa Utilisation d'alkyl monoglucosides en tant que vecteurs moleculaires
FR2791679B1 (fr) * 1999-03-31 2003-04-11 Fabre Pierre Dermo Cosmetique Bioprecurseurs aptes a liberer un derive retinoique par mise a profit de l'activite enzymatique de la surface cutanee et compositions pharmaceutiques et/ou cosmetiques
US20050148534A1 (en) * 2003-09-22 2005-07-07 Castellino Angelo J. Small molecule compositions and methods for increasing drug efficiency using compositions thereof
BRPI0513145A (pt) * 2004-07-09 2008-04-29 Dsm Ip Assets Bv conjugados de amino, aminoácido ou peptìdeo de ácido retinóico
TW200918099A (en) * 2007-09-14 2009-05-01 Nitto Denko Corp Drug carriers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219657A (en) * 1961-02-27 1965-11-23 Monsanto Co Saccharide polydicarboxylate half-esters
US4224244A (en) * 1973-03-30 1980-09-23 Hoffmann-La Roche Inc. 9-Phenyl 5,6-dimethyl-nona-2,4,6,8 tetraenal or tetraenol derivatives
CH585166A5 (da) * 1973-03-30 1977-02-28 Hoffmann La Roche
US4215215A (en) * 1975-08-01 1980-07-29 Hoffmann-La Roche Inc. 9-Phenyl-nonate traene compounds
LU77254A1 (da) * 1977-05-04 1979-01-18
JPS5640651A (en) * 1979-09-12 1981-04-16 Takeda Chem Ind Ltd Quinone compound and its preparation
FI67386C (fi) * 1979-06-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sockerderivat

Also Published As

Publication number Publication date
BE901210A (fr) 1985-06-05
DK587384A (da) 1985-06-09
DE3444051C2 (de) 1994-08-04
IT8423661A1 (it) 1986-05-20
JPH0524920B2 (da) 1993-04-09
CH661516A5 (de) 1987-07-31
FR2556348B1 (fr) 1988-10-14
IT8423661A0 (it) 1984-11-20
US4565863A (en) 1986-01-21
SE8406138D0 (sv) 1984-12-04
GB2152498A (en) 1985-08-07
IT1177263B (it) 1987-08-26
AU3514384A (en) 1985-06-13
NL8403554A (nl) 1985-07-01
SE8406138L (sv) 1985-06-09
DK587384D0 (da) 1984-12-07
CA1234107A (en) 1988-03-15
DE3444051A1 (de) 1985-06-13
ZA849364B (en) 1985-07-31
SE468987B (sv) 1993-04-26
AU571278B2 (en) 1988-04-14
JPS60146896A (ja) 1985-08-02
GB2152498B (en) 1987-09-09
DK163585B (da) 1992-03-16
GB8430915D0 (en) 1985-01-16
FR2556348A1 (fr) 1985-06-14

Similar Documents

Publication Publication Date Title
DK163585C (da) Retinoidcarboxylsyre-mono- og -disaccharidestere, disse estere til anvendelse som laegemidler, isaer til behandling af neoplasi, acne eller psoriasis, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse estere samt anvendelse af esterne til fremstilling af et middel til behandling af neoplasi, acne eller psoriasis
DE3482812D1 (de) Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DK160981C (da) Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater
DE3770982D1 (de) Diphosphonsaeure-verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel.
DE3680216D1 (de) Titandioxidteilchen und verfahren zu ihrer herstellung.
DE3484925D1 (de) Pyrazolochinoline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DK423184A (da) 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin d og farmaceutisk acceptable salte deraf samt forbindelser til anvendelse som mellemprodukter ved fremstilling deraf
DK157016C (da) 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat, laegemidler indeholdende dette samt fremstilling af disse laegemidler
DK506386A (da) Flavonderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
ZA821637B (en) Oxazaphosphorin-4-thio-alkanesulfonic acids, neutral salts thereof, processes for the production thereof and pharmaceutical preparations containing them
DE3766299D1 (de) 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DK354188D0 (da) Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen
DK165880C (da) Androstan-17beta-carboxylsyreestere, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat indeholdende samme
DK116689D0 (da) Pyrroloquinolin- og pyrrolophenothiazin-carboxamider og beslaegtede forbindelser samt farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af laegemidler til behandling af inflammation eller andre prostaglandin- eller leukotrin-formidlede sygdomme
DE3481512D1 (de) Aroylbenzofuran- und aroylbenzothiophenessigsaeuren und -propionsaeuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3674521D1 (de) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte.
DE3670635D1 (de) Neue benzisoselenazolonyl-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE3670638D1 (de) Indol-3-yl-chinazolin-1,4-benzodiazepin-5,13-dione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
NO179632C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat som inneholder podofyllotoksin
DE3481418D1 (de) Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen.
DK567184D0 (da) Pyridonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
DE3681701D1 (de) Chinazolin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und ihre verwendung.
AU3707884A (en) Silane-modified ester mixtures, process for the production thereof and use thereof in pharmaceutical and cosmetic preparations
DE3380989D1 (de) 2-aminobenzosaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen.
DE3774359D1 (de) 3-(1h-tetrazol-5-yl)oxanilsaeure, salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.